Concomitant administration of nitric oxide and glucocorticoids improves protection against bronchoconstriction in a murine model of asthma

Journal of Applied Physiology

Volumn 109, Issue 2, 2010, Pages 521-531

  Jonasson, Sofia ^a   Hedenstierna, Göran ^a   Hjoberg, Josephine ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Airway inflammation; Forced oscillation; Glucocorticoid sensitivity; Lung mechanics

Indexed keywords

1,1-DIETHYL-2-HYDROXY-2-NITROSOHYDRAZINE; 1H-(1,2,4)OXADIAZOLO(4,3-A)QUINOXALIN-1-ONE; ANTIASTHMATIC AGENT; BRONCHOCONSTRICTING AGENT; CELL RECEPTOR; CYCLIC GMP; ENZYME INHIBITOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GUANYLATE CYCLASE; HYDRAZINE DERIVATIVE; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE, ESCHERICHIA COLI 0111 B4; METHACHOLINE CHLORIDE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; OVALBUMIN; OXADIAZOLE DERIVATIVE; QUINOXALINE DERIVATIVE; SOLUBLE GUANYLYL CYCLASE;

AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; ARTIFICIAL VENTILATION; ASTHMA; BAGG ALBINO MOUSE; BREATHING MECHANICS; BRONCHOCONSTRICTION; CHEMICALLY INDUCED; DIAGNOSTIC USE; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECTS; FEMALE; INHALATION TEST; INHALATIONAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PNEUMONIA;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; CYCLIC GMP; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; GLUCOCORTICOIDS; GUANYLATE CYCLASE; HYDRAZINES; HYDROCORTISONE; INJECTIONS, INTRAPERITONEAL; LIPOPOLYSACCHARIDES; METHACHOLINE CHLORIDE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; OVALBUMIN; OXADIAZOLES; PNEUMONIA; QUINOXALINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, GLUCOCORTICOID; RESPIRATION, ARTIFICIAL; RESPIRATORY MECHANICS;

EID: 77955616912     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01317.2009     Document Type: Article

References (58)

1. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 6: 1368-1370, 1993.
2. Barnes PJ. Distribution of receptor targets in the lung. Proc Am Thorac Soc 1: 345-351, 2004.
3. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 8: 183-192, 2008.
4. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 373: 1905-1917, 2009.
5. Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: an update. Pharmacol Rev 50: 515-596, 1998.
6. Basit A, Reutershan J, Morris MA, Solga M, Rose CE Jr, Ley K. ICAM-1 and LFA-1 play critical roles in LPS-induced neutrophil recruitment into the alveolar space. Am J Physiol Lung Cell Mol Physiol 291: L200-L207, 2006.
7. Bates JH, Irvin CG. Measuring lung function in mice: the phenotyping uncertainty principle. J Appl Physiol 94: 1297-1306, 2003.
8. Bochner BS, Busse WW. Allergy and asthma. J Allergy Clin Immunol 115: 953-959, 2005.
9. Brass DM, Hollingsworth JW, Cinque M, Li Z, Potts E, Toloza E, Foster WM, Schwartz DA. Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis. Am J Respir Cell Mol Biol 39: 584-590, 2008.
10. Brönnegard M, Stierna P, Marcus C. Glucocorticoid resistant syndromes- molecular basis and clinical presentations. J Neuroendocrinol 8: 405-415, 1996.
11. Charmandari E, Kino T, Chrousos GP. Glucocorticoids and their actions: an introduction. Ann NY Acad Sci 1024: 1-8, 2004.
12. Chetta A, Marangio E, Olivieri D. Inhaled steroids and airway remodelling in asthma. Acta Biomed Ateneo Parmense 74: 121-125, 2003.
13. Da J, Chen L, Hedenstierna G. Nitric oxide up-regulates the glucocorticoid receptor and blunts the inflammatory reaction in porcine endotoxin sepsis. Crit Care Med 35: 26-32, 2007.
14. Delayre-Orthez C, Becker J, de Blay F, Frossard N, Pons F. Exposure to endotoxins during sensitization prevents further endotoxin-induced exacerbation of airway inflammation in a mouse model of allergic asthma. Int Arch Allergy Immunol 138: 298-304, 2005.
15. Delayre-Orthez C, de Blay F, Frossard N, Pons F. Dose-dependent effects of endotoxins on allergen sensitization and challenge in the mouse. Clin Exp Allergy 34: 1789-1795, 2004.
16. Duma D, Silva-Santos JE, Assreuy J. Inhibition of glucocorticoid receptor binding by nitric oxide in endotoxemic rats. Crit Care Med 32: 2304-2310, 2004.
17. Fischer A, Folkerts G, Geppetti P, Groneberg DA. Mediators of asthma: nitric oxide. Pulm Pharmacol Ther 15: 73-81, 2002.
18. Foster MW, Forrester MT, Stamler JS. A protein microarray-based analysis of S-nitrosylation. Proc Natl Acad Sci USA 106: 18948-18953, 2009.
19. Galigniana MD, Piwien-Pilipuk G, Assreuy J. Inhibition of glucocorticoid receptor binding by nitric oxide. Mol Pharmacol 55: 317-323, 1999.
20. Gaston B, Singel D, Doctor A, Stamler JS. S-nitrosothiol signaling in respiratory biology. Am J Respir Crit Care Med 173: 1186-1193, 2006.
21. Gerhold K, Blumchen K, Bock A, Franke A, Avagjan A, Hamelmann E. Endotoxins and allergy: lessons from the murine model. Pathobiology 70: 255-259, 2002.
22. Gerhold K, Blumchen K, Bock A, Seib C, Stock P, Kallinich T, Lohning M, Wahn U, Hamelmann E. Endotoxins prevent murine IgE production, TH2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol 110: 110-116, 2002.
23. Gomes RF, Shen X, Ramchandani R, Tepper RS, Bates JH. Comparative respiratory system mechanics in rodents. J Appl Physiol 89: 908-916, 2000.
24. Hantos Z, Daroczy B, Suki B, Nagy S, Fredberg JJ. Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol 72: 168-178, 1992.
25. Hjoberg J, Shore S, Kobzik L, Okinaga S, Hallock A, Vallone J, Subramaniam V, De Sanctis GT, Elias JA, Drazen JM, Silverman ES. Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness. J Appl Physiol 97: 249-259, 2004.
26. Ha°llström L, Berghall E, Frostell C, Sollevi A, Soop AL. Nitric oxide inhalation and glucocorticoids as combined treatment in human experimental endotoxemia. Crit Care Med 36: 3043-3047, 2008.
27. Iijima H, Duguet A, Eum SY, Hamid Q, Eidelman DH. Nitric oxide and protein nitration are eosinophil dependent in allergen-challenged mice. Am J Respir Crit Care Med 163: 1233-1240, 2001.
28. Irvin CG, Bates JH. Measuring the lung function in the mouse: the challenge of size. Respir Res 4: 4, 2003.
29. Ito K, Chung KF, Adcock IM. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 117: 522-543, 2006.
30. Ito K, Hanazawa T, Tomita K, Barnes PJ, Adcock IM. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun 315: 240-245, 2004.
31. Ji JY, Diamond SL. Exogenous nitric oxide activates the endothelial glucocorticoid receptor. Biochem Biophys Res Commun 318: 192-197, 2004.
32. Jonasson S, Hedenstierna G, Hedenström H, Hjoberg J. Comparisons of effects of intravenous and inhaled methacholine on airway physiology in a murine asthma model. Respir Physiol Neurobiol 165: 229-236, 2009.
33. Jonasson S, Swedin L, Lundqvist M, Hedenstierna G, Dahlén SE, Hjoberg J. Different effects of deep inspirations on central and peripheral airways in healthy and allergen-challenged mice. Respir Res 9: 23, 2008.
34. Kalinyak JE, Dorin RI, Hoffman AR, Perlman AJ. Tissue-specific regulation of glucocorticoid receptor mRNA by dexamethasone. J Biol Chem 262: 10441-10444, 1987.
35. Kikuchi S, Nagata M, Kikuchi I, Hagiwara K, Kanazawa M. Association between neutrophilic and eosinophilic inflammation in patients with severe persistent asthma. Int Arch Allergy Immunol 137, Suppl 1: 7-11, 2005.
36. Komlósi ZI, Pozsonyi E, Tabi T, Szoko E, Nagy A, Bartos B, Kozma GT, Tamasi L, Orosz M, Magyar P, Losonczy G. Lipopolysaccharide exposure makes allergic airway inflammation and hyper-responsiveness less responsive to dexamethasone and inhibition of iNOS. Clin Exp Allergy 36: 951-959, 2006.
37. Kurihara I, Shibata H, Suzuki T, Ando T, Kobayashi S, Hayashi M, Saito I, Saruta T. Expression and regulation of nuclear receptor coactivators in glucocorticoid action. Mol Cell Endocrinol 189: 181-189, 2002.
38. Lu NZ, Cidlowski JA. The origin and functions of multiple human glucocorticoid receptor isoforms. Ann NY Acad Sci 1024: 102-123, 2004.
39. Mayer B, Pfeiffer S, Schrammel A, Koesling D, Schmidt K, Brunner F. A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione. J Biol Chem 273: 3264-3270, 1998.
40. Murakami D, Yamada H, Yajima T, Masuda A, Komune S, Yoshikai Y. Lipopolysaccharide inhalation exacerbates allergic airway inflammation by activating mast cells and promoting Th2 responses. Clin Exp Allergy 37: 339-347, 2007.
41. Nevin BJ, Broadley KJ. Comparative effects of inhaled budesonide and the NO-donating budesonide derivative, NCX 1020, against leukocyte influx and airway hyperreactivity following lipopolysaccharide challenge. Pulm Pharmacol Ther 17: 219-232, 2004.
42. Nijkamp FP, Folkerts G. Nitric oxide and bronchial hyperresponsiveness. Arch Int Pharmacodyn Ther 329: 81-96, 1995.
43. Paul-Clark M, Del Soldato P, Fiorucci S, Flower RJ, Perretti M. 21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties. Br J Pharmacol 131: 1345-1354, 2000.
44. Paul-Clark MJ, Roviezzo F, Flower RJ, Cirino G, Soldato PD, Adcock IM, Perretti M. Glucocorticoid receptor nitration leads to enhanced anti-inflammatory effects of novel steroid ligands. J Immunol 171: 3245-3252, 2003.
45. Poynter ME, Irvin CG, Janssen-Heininger YM. A prominent role for airway epithelial NF-kappaB activation in lipopolysaccharide-induced airway inflammation. J Immunol 170: 6257-6265, 2003.
46. Pujols L, Mullol J, Torrego A, Picado C. Glucocorticoid receptors in human airways. Allergy 59: 1042-1052, 2004.
47. Que LG, Liu L, Yan Y, Whitehead GS, Gavett SH, Schwartz DA, Stamler JS. Protection from experimental asthma by an endogenous bronchodilator. Science 308: 1618-1621, 2005.
48. Raychaudhuri B, Dweik R, Connors MJ, Buhrow L, Malur A, Drazba J, Arroliga AC, Erzurum SC, Kavuru MS, Thomassen MJ. Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages. Am J Respir Cell Mol Biol 21: 311-316, 1999.
49. Ricciardolo FL. Multiple roles of nitric oxide in the airways. Thorax 58: 175-182, 2003.
50. Suzuki H. New insight from the interplay between nitric oxide and glucocorticoids. Crit Care Med 32: 2362-2363, 2004.
51. Thomassen MJ, Raychaudhuri B, Dweik RA, Farver C, Buhrow L, Malur A, Connors MJ, Drazba J, Hammel J, Erzurum SC, Kavuru MS. Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge. J Allergy Clin Immunol 104: 1174-1182, 1999.
52. Tulić MK, Knight DA, Holt PG, Sly PD. Lipopolysaccharide inhibits the late-phase response to allergen by altering nitric oxide synthase activity and interleukin-10. Am J Respir Cell Mol Biol 24: 640-646, 2001.
53. Tulić MK, Wale JL, Holt PG, Sly PD. Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 22: 604-612, 2000.
54. Vignery A. Macrophage fusion: the making of osteoclasts and giant cells. J Exp Med 202: 337-340, 2005.
55. Wallace JL, Rizzo G, Cirino G, Del Soldato P, Fiorucci S. Enhanced anti-inflammatory potency of a nitric oxide-releasing derivative of flunisolide: role of nuclear factor-kappaB. J Pharmacol Exp Ther 310: 1096-1102, 2004.
56. Wenzel S. Mechanisms of severe asthma. Clin Exp Allergy 33: 1622-1628, 2003.
57. Wishah K, Malur A, Raychaudhuri B, Melton AL, Kavuru MS, Thomassen MJ. Nitric oxide blocks inflammatory cytokine secretion triggered by CD23 in monocytes from allergic, asthmatic patients and healthy controls. Ann Allergy Asthma Immunol 89: 78-82, 2002.
58. Zingarelli B, Hasko G, Salzman AL, Szabo C. Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock. Crit Care Med 27: 1701-1707, 1999.